{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17212051", "DateCompleted": {"Year": "2007", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2007", "Month": "01", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-4454", "JournalIssue": {"Volume": "29", "Issue": "9", "PubDate": {"Year": "2006", "Month": "Sep"}}, "Title": "Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials", "ISOAbbreviation": "Zhong Yao Cai"}, "ArticleTitle": "[Determination of ginsenoside rd in human plasma by LC/MS/MS].", "Pagination": {"StartPage": "928", "EndPage": "931", "MedlinePgn": "928-31"}, "Abstract": {"AbstractText": ["To develop a HPLC/MS/MS method for the determination of ginsenoside Rd in human plasma.", "Plasma samples were pretreated by solid phase extraction (SPE). Ginsenoside Rd (m/z 964.6-->m/z 767.5) and gentiopicrin (m/z 374.1-->195.1) was detected by the positive electrospray ionization (ES+I)-MS method under multiple reaction monitoring (MRM) mode.", "The calibration curve of ginsenoside Rd in plasma was linear over the range of 3.00-5000.00 ng/ml. The limit of quantitation was 3.00 ng/ml. The relative recovery was 81.01-83.39%. The within-day and between-day RSDs were less than 15%. CONCLUSION This method is accurate, sensitive, and specific. It is suitable for the measurement of plasma ginsenoside Rd concentration."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China."}], "Identifier": [], "LastName": "Deng", "ForeName": "Yuan-hui", "Initials": "YH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Feng", "ForeName": "Yi", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zeng", "ForeName": "Xing", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yang", "ForeName": "Liu", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Yi-ming", "Initials": "YM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huang", "ForeName": "Yu", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sun", "ForeName": "Jing", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Dan", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liang", "ForeName": "Wei-xiong", "Initials": "WX"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Yao Cai", "NlmUniqueID": "9426370", "ISSNLinking": "1001-4454"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Area Under Curve"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": [], "DescriptorName": "Drug Stability"}, {"QualifierName": ["administration & dosage", "blood", "pharmacokinetics"], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Injections, Intravenous"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Sensitivity and Specificity"}, {"QualifierName": ["methods"], "DescriptorName": "Tandem Mass Spectrometry"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "1", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "10", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "1", "Day": "11", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17212051"]}}], "PubmedBookArticle": []}